- Home
- GBLI vs CMPS Comparison
GBLI vs CMPS Comparison
Compare GBLI & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBLI
- CMPS
- Stock Information
- Founded
- GBLI 2016
- CMPS 2020
- Country
- GBLI United States
- CMPS United Kingdom
- Employees
- GBLI N/A
- CMPS N/A
- Industry
- GBLI Property-Casualty Insurers
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- GBLI Finance
- CMPS Health Care
- Exchange
- GBLI Nasdaq
- CMPS Nasdaq
- Market Cap
- GBLI 421.5M
- CMPS 364.9M
- IPO Year
- GBLI 2003
- CMPS 2020
- Fundamental
- Price
- GBLI $29.20
- CMPS $4.61
- Analyst Decision
- GBLI
- CMPS Strong Buy
- Analyst Count
- GBLI 0
- CMPS 7
- Target Price
- GBLI N/A
- CMPS $17.00
- AVG Volume (30 Days)
- GBLI 5.9K
- CMPS 1.8M
- Earning Date
- GBLI 08-06-2025
- CMPS 07-31-2025
- Dividend Yield
- GBLI 4.79%
- CMPS N/A
- EPS Growth
- GBLI N/A
- CMPS N/A
- EPS
- GBLI 1.98
- CMPS N/A
- Revenue
- GBLI $439,280,000.00
- CMPS N/A
- Revenue This Year
- GBLI $7.67
- CMPS N/A
- Revenue Next Year
- GBLI $7.93
- CMPS N/A
- P/E Ratio
- GBLI $14.72
- CMPS N/A
- Revenue Growth
- GBLI N/A
- CMPS N/A
- 52 Week Low
- GBLI $26.94
- CMPS $2.25
- 52 Week High
- GBLI $37.00
- CMPS $8.54
- Technical
- Relative Strength Index (RSI)
- GBLI 45.18
- CMPS 60.45
- Support Level
- GBLI $28.76
- CMPS $3.97
- Resistance Level
- GBLI $30.00
- CMPS $4.42
- Average True Range (ATR)
- GBLI 1.04
- CMPS 0.22
- MACD
- GBLI 0.06
- CMPS -0.01
- Stochastic Oscillator
- GBLI 46.46
- CMPS 91.43
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance world-wide. The company's two segments are: Penn-America and Non-Core Operations. The Penn-America segment offers specialty property and casualty products designed for its Wholesale Commercial, Specialty Products, InsurTech, and Assumed Reinsurance product offerings. These product lines are offered in the excess and surplus lines marketplace; and Non-Core Operations segment contains lines of business that have been de-emphasized or are no longer being written. The majority of its revenue is from the the Penn-America segment . Geographically, the majority is from California.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.